Clinical Trial of Keluoxin Capsules in the Treatment of Diabetic Kidney Disease with Diabetic Retinopathy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 460 participants.
Also called NCT06660940
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 460 participants
- Sponsor
- Registry
-
NCT06660940
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06660940. Randomized; quadruple masking; primary purpose treatment. Start 2024-10 (anticipated); primary completion 2027-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial of Keluoxin Capsules in the Treatment of Diabetic Kidney Disease with Diabetic Retinopathy
- Condition
- Diabetic Kidney Disease
- Condition
- Diabetic Retinopathy
- Intervention (Drug)
- Keluoxin Capsules
- Intervention (Drug)
- Keluoxin Capsule Simulants
- Intervention (Drug)
- Irbesartan
- Lead sponsor
- Chinese PLA General Hospital
Record details
- Record id
cardio:ct-nct06660940- Content hash
0f105bc403a0df5c371ce6e049e2accf95bea15c8f70d750da1dae4dd813bd05